X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Perceptive Advisors LLC reported a 7.60% stake in X4 Pharmaceuticals, Inc. (Schedule 13G)
Event Oct 27, 2025 · Filed Nov 3, 2025
Perceptive Advisors LLC reported a 7.60% stake in X4 Pharmaceuticals, Inc., 6,064,680 shares, as a passive investor on Oct 27, 2025. Filed Nov 3, 2025 (Schedule 13G).
- Stake
- 7.60%
- Shares
- 6,064,680
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 7.60% | 6,064,680 |
| Joseph Edelman | 7.60% | 6,064,680 |
| Perceptive Life Sciences Master Fund, Ltd. | 7.60% | 6,064,680 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Perceptive Advisors LLC
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026